Published source snapshot

DNZ-2 250 mg

Bio-Tech Pharmacal · US label facts

Label IDlbl_dsld_217554_b71492e41c488625
Serving size1 Capsule(s)
Serving formCapsule(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.

Original facts and normalized results

IngredientOriginal label quantityRequested normalizationMeasurement object
Deanol
Deanol p-Acetamidobenzoate Note: providing; DSLD row path: root.0; DSLD ingredientId: 242525
250 mg250 mg / as_labeledDeanol p-Acetamidobenzoate
Deanol
DSLD row path: root.0.nested.0; DSLD ingredientId: 46407
83 mg83 mg / as_labeledDMAE
capsule
Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 7420.
Not statedmissing_quantityGelatin Capsule

Label statements

These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.

Ingredient references

Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.

Source and version

Original record
NIH ODS DSLD label 217554
Local snapshot
snap_dsld_217554_b71492e41c4886251784e6da
Content hash
b71492e41c4886251784e6da186d79206549f516b71ec59b660af60becfd8704
Source version
PC# 53191-123-01

Limitations

Read this label as Markdown · Read as JSON